Ara
Toplam kayıt 2, listelenen: 1-2
Tyrosine kinase inhibitors and COVID-19
(Sage Publications Ltd, 2020)
[No Abstract Available]
The outcome of COVID-19 in patients with hematological malignancy (Letter)
(Wiley, 2021)
[No Abstract Available]